Cellectar Biosciences, Inc. announced it raised $20.5 Million in an initial filing from an offering of $20.5 Million

Jan 08, 2021•over 4 years ago

Amount Raised

$20.5 Million

Florham ParkHealthcare

Company Information

Company

Cellectar Biosciences, Inc.

Location

100 CAMPUS DRIVE

Florham Park, New Jersey, United States

About

Cellectar Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Cellectar Biosciences, Inc. announced it raised $20.5 Million in an initial filing from an offering of $20.5 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information